Two Sigma Investments’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-359,930
| Closed | -$3.25M | – | 4952 |
|
|
2025
Q4 | $3.25M | Sell |
359,930
-76,152
| -17% | -$569K | ﹤0.01% | 2084 |
|
|
2025
Q3 | $1.36M | Buy |
+436,082
| New | +$1.16M | ﹤0.01% | 2385 |
|
|
2025
Q1 | – | Sell |
-476,291
| Closed | -$1.04M | – | 3514 |
|
|
2024
Q4 | $1.04M | Buy |
476,291
+211,421
| +80% | +$479K | ﹤0.01% | 2151 |
|
|
2024
Q3 | $577K | Buy |
264,870
+28,096
| +12% | +$64.6K | ﹤0.01% | 2401 |
|
|
2024
Q2 | $547K | Buy |
236,774
+149,174
| +170% | +$620K | ﹤0.01% | 2322 |
|
|
2024
Q1 | $482K | Sell |
87,600
-1,040,938
| -92% | -$4.76M | ﹤0.01% | 2354 |
|
|
2023
Q4 | $2.79M | Buy |
1,128,538
+1,083,138
| +2,386% | +$10.3M | 0.01% | 1304 |
|
|
2023
Q3 | $1.58M | Sell |
45,400
-44,291
| -49% | -$1.53M | ﹤0.01% | 1602 |
|
|
2023
Q2 | $2.94M | Buy |
89,691
+50,340
| +128% | +$1.74M | 0.01% | 1209 |
|
|
2023
Q1 | $1.32M | Sell |
39,351
-36,818
| -48% | -$1.43M | ﹤0.01% | 1713 |
|
|
2022
Q4 | $2.5M | Sell |
76,169
-15,226
| -17% | -$451K | 0.01% | 1207 |
|
|
2022
Q3 | $3.19M | Buy |
+91,395
| New | +$2.02M | 0.01% | 951 |
|
|
2022
Q1 | – | Sell |
-10,760
| Closed | -$214K | – | 4412 |
|
|
2021
Q4 | $214K | Buy |
+10,760
| New | +$204K | ﹤0.01% | 3893 |
|
Other funds holding VTYX
Two Sigma Investments's VTYX Position: Q1 2026 in Review
Two Sigma Investments sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 359,930 shares — an estimated $3.25M sold.
Two Sigma Investments first reported a position in VTYX in Q4 2021 and held it in 13 quarters. The position peaked at $3.25M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Two Sigma Investments reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Two Sigma Investments sold 359,930 Ventyx Biosciences shares in Q1 2026, an estimated $3.25M.
- Two Sigma Investments first reported a position in Ventyx Biosciences in Q4 2021 and held it in 13 quarters.
- Two Sigma Investments's Ventyx Biosciences position peaked at $3.25M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.